CSF News & Events
From CSF to Liquidity:
A major milestone for Cannatrek and their CSF Investors
Liquidation Event
In December 2020, Cannatrek raised $2.5m via CSF on OnMarket from 720 investors, the largest crowd-sourced funding offer of that year. Like all CSF investments, there was no guaranteed path to exit.
In Early 2026, Little Green Pharma (ASX: LGP) announced a binding Scheme Implementation Deed to acquire 100% of Cannatrek via a scheme of arrangement. This means, Cannatrek's shareholders including those 720 CSF investors, will receive listed securities in exchange for their holdings.
Under the proposed transaction, Cannatrek shareholders will receive (per Cannatrek share):
-
1.835806 new LGP shares
-
0.727502 contingent value shares (CV Shares)
Why this matters?
One of the most common questions we hear from CSF investors is: how do I eventually realise value from my investment? CSF shares in unlisted companies don't come with a ready-made secondary market. Liquidity depends on future events, a trade sale, an IPO, or, as here, an acquisition by a listed entity.
This transaction is a strong example of the CSF journey. Investors who backed Cannatrek in 2020 are now positioned to hold ASX listed shares, gaining access to liquidity they did not have before. It shows how CSF can lead to a tangible equity outcome when a company executes well.
For founders, it highlights that CSF is more than just capital. It builds a shareholder base, increases visibility and helps establish the foundations for future transactions and for everyday investors It provides clear evidence that CSF can deliver real outcomes.
For OnMarket and our investor community, this is exactly the kind of outcome that makes CSF so compelling. One of the biggest barriers for everyday investors considering private company opportunities is the question of eventual return and liquidity. Transactions like this help demonstrate that while CSF investments are long-term and outcomes are never guaranteed, there is a real pathway to value realisation when a business performs and a strategic transaction emerges.
This reinforces the quality of companies raising on the OnMarket platform and the role CSF can play in connecting retail investors with genuine equity upside. For investors, it is a tangible example that backing the right business at the right stage can lead not just to paper value, but to a meaningful ROI opportunity and access to listed market liquidity.
Congratulations to the teams at Cannatrek and Little Green Pharma. An important step for both businesses, their shareholders and the broader CSF market.